Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine, Biochemical and Biophysical Research Communications, September 2017, Elsevier,
DOI: 10.1016/j.bbrc.2017.06.178.
You can read the full text:
Contributors
The following have contributed to this page